Metformin and cancer: mounting evidence against an association.
about
Energy disruptors: rising stars in anticancer therapy?Breast Cancer Metabolism and Mitochondrial Activity: The Possibility of Chemoprevention with MetforminPredictors of prevalent statin use among older adults identified as statin initiators based on Medicare claims data.Within-class differences in cancer risk for sulfonylurea treatments in patients with type 2 diabetes (ZODIAC-55) - a study protocol.Clinical benefits of metformin in gynecologic oncology.Are metformin, statin and aspirin use still associated with overall mortality among colorectal cancer patients with diabetes if adjusted for one another?Association between type 2 diabetes and cancer incidence in Taiwan: data from a prospective community-based cohort study.Metformin inhibits gastric cancer cells metastatic traits through suppression of epithelial-mesenchymal transition in a glucose-independent manner.Diabetes, metformin and incidence of and death from invasive cancer in postmenopausal women: Results from the women's health initiative.A retrospective study on the role of diabetes and metformin in colorectal cancer disease survivalExpanding the therapeutic spectrum of metformin: from diabetes to cancer.The expanding role of metformin in cancer: an update on antitumor mechanisms and clinical development.No association between metformin use and survival in patients with pancreatic cancer: An observational cohort study.Potential and real 'antineoplastic' and metabolic effect of metformin in diabetic and nondiabetic postmenopausal females.No reduced risk of overall, colorectal, lung, breast, and prostate cancer with metformin therapy in diabetic patients: database analyses from Germany and the UK.Re.: "Reduced risk of lung cancer with metformin therapy in diabetic patients: a systematic review and meta-analysis".KRAS, YAP, and obesity in pancreatic cancer: A signaling network with multiple loops.Metformin as an anti-cancer agent: actions and mechanisms targeting cancer stem cells.Metformin Decreases the Incidence of Pancreatic Ductal Adenocarcinoma Promoted by Diet-induced Obesity in the Conditional KrasG12D Mouse Model.
P2860
Q26771300-A6F89EFC-1FD4-4A00-A30A-D5371FB2C120Q26775580-CF4B60BB-06F6-4BAC-9E91-5E1CA21D0404Q31060524-98B61E41-BED0-4E3C-B97B-E9800285C569Q33830390-9413CE12-7528-4A92-B071-4764B028B12DQ35871269-83DA27F4-1835-4644-83BF-23139E8F6F4FQ35909683-1F829C9C-0C35-4657-A64D-A8E1598B5F3CQ36278009-1E8EC315-DD0E-4B3E-BE31-492A59D8432FQ36320084-75AB611A-2409-4267-AED3-AED2E9209249Q36794283-7A281729-5BCA-4F74-A65B-E0D44F719808Q36807881-7DA902B9-FBB5-43FE-8D12-5C5FD6BC1AEBQ38558943-3FBE9A90-591F-45F1-BEC3-55575773E703Q38728567-B539850D-C624-45CB-9FD4-3DEC3945E6C6Q38748916-3C555818-CCCA-4045-90CD-56A2CD224738Q39030844-CA6C1ED6-8BFC-4FEE-A8FC-C45B00C10F6AQ40778391-4B86E925-FC35-49C9-871E-5823D10C3DB9Q43834371-C2D3A8F1-99FE-472A-9023-F2A7A4B90C37Q46471150-035266E2-C4E7-44BA-995A-14BEEF1CEC57Q50001260-401A36A4-82EB-47AC-AB56-3C5107B6B5C1Q52590946-DBDD670E-7AFE-406B-8702-6960345A40BA
P2860
Metformin and cancer: mounting evidence against an association.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Metformin and cancer: mounting evidence against an association.
@en
Metformin and cancer: mounting evidence against an association.
@nl
type
label
Metformin and cancer: mounting evidence against an association.
@en
Metformin and cancer: mounting evidence against an association.
@nl
prefLabel
Metformin and cancer: mounting evidence against an association.
@en
Metformin and cancer: mounting evidence against an association.
@nl
P356
P1433
P1476
Metformin and cancer: mounting evidence against an association.
@en
P2093
Laurent Azoulay
Samy Suissa
P304
P356
10.2337/DC14-0500
P407
P577
2014-07-01T00:00:00Z